Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
Didier HansMichael R McClungShuang HuangMin KimEnisa ShevrojaMichael McClungPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
, independently of BMD, and shifted more patients to lower fracture-risk categories.